Medicine ホーム > High Impact Papers > Health Sciences > TAS-102 monotherapy for pretreated metastatic colorectal cancer: A double-blind, randomised, placebo-controlled phase 2 trial TAS-102 monotherapy for pretreated metastatic colorectal cancer: A double-blind, randomised, placebo-controlled phase 2 trial代表者 : 森脇 俊和 © University of Tsukuba